| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 27 |
| 1 | BEVACIZUMAB | 20 |
| 2 | ASPIRIN | 15 |
| 3 | ASPIRIN 325 MG | 15 |
| 4 | ASPIRIN 81 MG | 15 |
| 5 | LEVOTHYROXINE SODIUM | 15 |
| 6 | CAPECITABINE | 14 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 12 |
| 8 | INTERFERON BETA-1A | 12 |
| 9 | METHOTREXATE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE AND ZINC CHLORIDE | 1 | 0.2000 |
| 1 | FERRIC SULFATE | 1 | 0.0125 |
| 2 | TIAGABINE HYDROCHLORIDE | 1 | 0.0119 |
| 3 | ALCLOMETASONE DIPROPIONATE | 1 | 0.0032 |
| 4 | DIFLUNISAL | 1 | 0.0012 |
| 5 | BETAXOLOL | 1 | 0.0012 |
| 6 | FLUTAMIDE | 1 | 0.0010 |
| 7 | IXABEPILONE | 1 | 0.0010 |
| 8 | CHOLESTERINUM | 1 | 0.0009 |
| 9 | TRABECTEDIN | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 1 | Benzodiazepine [EPC] | 23 |
| 2 | Corticosteroid [EPC] | 23 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 23 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 20 |
| 5 | Platinum-based Drug [EPC] | 18 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 18 |
| 7 | Atypical Antipsychotic [EPC] | 17 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 15 |
| 9 | Vitamin C [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 2 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 4 | Parenteral Iron Replacement [EPC] | 2 | 0.0001 |
| 5 | Nitrofuran Antibacterial [EPC] | 2 | 0.0001 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 20 | 0.0001 |
| 7 | Parathyroid Hormone Analog [EPC] | 12 | 0.0001 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Intestinal Lipase Inhibitor [EPC] | 2 | 0.0001 |